| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. My69z: 3 yrs ago -- ICI Agreement with major institution (6515)  (8) |
| 2. biloxiblues: Summary of Leronlimab’s Path and Regulatory (2687) (9) |
| 3. KenChowder: Note from Max Lataillade on LinkedIn in response (2649) (39) |
| 4. Cycl2R: I don’t believe it has been noted here that the (2371) (12) |
| 5. MJS719: Thank you brentie for the reminder of how (2366) (10) |
| 6. Evil Rabbit: I’ve repeatedly griped/whined/complained, (2268) (21) |
| 7. My69z: Dr. Sacha Project End Date 30-June-2025: "These (2249) (9) |
| 8. ohm20: OHM Thoughts??????????!!!!!! I have no idea what (2229) (2) |
| 9. Scuffler: Understood. But I think the lack of more (2143) (8) |
| 10. Scuffler: In response to the conversation about PR- Been (2143) (20) |
| 11. MGK_2: ohm, considering your last line, "A combination (2069) (6) |
| 12. Figgs: Do we have data from our 2021 trial: Leronlimab (1991) (5) |
| 13. My69z: I now think like some said --- even before mTNBC (1841) (5) |
| 14. MGK_2: I think you're spot on mfglola. I wrote (1490) (13) |
| 15. MGK_2: I have a question on a (1463) (2) |
| 16. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (1454) |
| 17. Wharfrat: David Dalton comments on LI (same day as last (1238) (10) |
| 18. My69z: This abstract answers alot: Doubling the mOS (1204) (6) |
| 19. Chasing Stars: Getting started on Investors Hangout. Are you (1113) (14) |
| 20. sjacobs26: My calculator broke on the third oncology (917) (23) |
| 21. z_smith01: We have talked about this a lot over the years. (812) (33) |
| 22. mightycydy: New post by Dr. Max Lataillade re: Leronlimab (802) (31) |
| 23. My69z: Employment Agreement between CytoDyn Inc. and (777) (6) |
| 24. ScottyDoggs: Someone else brought this up on another website (772) (5) |
| 25. My69z: The global chemotherapy market was valued at USD (768) (7) |
| 26. USS JOHNSTON: Great find re Dr Max's linkedin post, mighty, and (756) (26) |
| 27. My69z: Few weeks ago i said if eventually the FDA goes (751) (3) |
| 28. sean007: An individual went conservative on this (748) (9) |
| 29. mikeyt1818: Great post. That reminds me of late 2018 and (743) (4) |
| 30. My69z: PD-L1 journey clarity.... Basket Study of (734) (3) |
| 31. Albert364: Love International Group, Inc. (LOVV) is a (728) |
| 32. ohm20: "Brain cancer patient DJ Daniel faces 3 new (714) (9) |
| 33. Hanman: Because it will cost about $28K per year per (712) (4) |
| 34. skezan: I guess the FDA approval of lenacapavir explains (708) (15) |
| 35. My69z: Multiple loose-end trials. CFO blocked for 1 yr @ (703) (5) |
| 36. Blindspot: News on the other board. Looks like about $6.5 (702) (1) |
| 37. Evil Rabbit: Cytodyn is not a buy-out. Cytodyn is a build-out. (688) (22) |
| 38. USS JOHNSTON: Just an FYI, I messaged someone on Linked-in last (686) (21) |
| 39. Blindspot: Didn't peeps here see the latest news? Nothing to (682) |
| 40. dfwl28: "An individual went conservative on this (682) (12) |
| 41. DJknows: Nice post on LinkedIn by Max Latallaide entitled: (680) (8) |
| 42. Kanola: He was at the back of the Brain Line and got what (679) |
| 43. My69z: Past BTD application -- WOW !! All patients in (677) (4) |
| 44. Evil Rabbit: To me, not enough data in 3 - 12 months to (676) (15) |
| 45. sunray3: And yet here the Gates foundation is endorsing (674) |
| 46. misiu143: Excellent point Evil , During quiet period , or (668) (8) |
| 47. Mr3Putt: 134eP - Observed Survival Following Treatment (668) (11) |
| 48. Rosner: Short Interest Report As of Sat, Aug 3, '13 (664) |
| 49. BigSur25: I’m over at WOGI (659) |
| 50. My69z: Gilead -- 2 drugs: Tuesday, April 29, 2025 U.S. (659) (7) |
